This domain is sufficient for inhibition of H3K18 acetylation and p300 mediated H3K18 acetylation in reconstituted chromatin in vivo, and it is known that hypoacetylation of histone H3 at this position is correlated with aggressive tumor phenotypes and poor prognosis in different cancers [129,130,131]. The gene discussed is EP300; the disease is cancer.